Genetic Testing – Prohibitions on Disability, Life, and Long–Term Care Insurance and Educational Materials (Genetic Testing Protection Act of 2023)
The implementation of HB155 is expected to have a significant impact on state insurance laws, ensuring that genetic information cannot be utilized against individuals when seeking life and disability insurance. This change seeks to dismantle barriers that have historically made it challenging for certain individuals, particularly those with genetic predispositions to health conditions, to obtain necessary coverage. The law affects not only the insurance providers’ obligations but also mandates that the Maryland Department of Health updates educational materials on genetic testing to better inform the public about their rights and options.
House Bill 155, titled the Genetic Testing Protection Act of 2023, introduces prohibitions on how life insurance, long-term care insurance, and disability insurance providers can operate concerning applicants who have undergone genetic testing. The bill explicitly prevents these insurance carriers from denying coverage or altering policy terms based on an individual's genetic testing status or results. This legislative move aims to protect individuals from potential discrimination stemming from their genetic information, thereby promoting equity in access to insurance products.
While the bill has garnered support from advocates for discrimination protections, there remain notable contentions surrounding its implementation. Critics voice concerns that such prohibitions might lead to higher insurance premiums overall, as insurers adapt their pricing strategies in response to restricted data utilization. Additionally, there may be debates surrounding the balance between privacy rights and the need for insurers to adequately assess risk, raising questions about potential unintended consequences of the bill as it progresses through legislative scrutiny.